Newsroom
Alarming Results: Androgen-Deprivation in Early-Stage Prostate Cancer Patients May Not Influence Long-Term Survival
The long-term study, published in JAMA Internal Medicine, was conducted in more than 65,000 men over the age of 66 years with early-stage prostate cancer.
Genentech's Avastin Granted Priority Review: Cervical Cancer
Genentech submitted the BLA for bevacizumab for the treatment of recurrent or metastatic cervical cancer.
Narrow Provider Networks Set to Spread
As the healthcare industry focuses on cutting costs, narrow provider networks designed to deliver value are taking hold as a widespread business practice.
Doctors' Employment Contracts Due For Renewal—and Revamp
Physician employment contracts with hospitals that were signed in the early days of healthcare reform are coming up for renewal Experts say the expectation of payment reform requires that these new deals include the flexibility to adapt to expected and unforseeable changes.
Literature: Method of Acquiring Tumor Samples Can Influence Proteomic Biomarkers
The authors sought to determine if tumor heterogeneity and biospecimen variables affect the evaluation of PI3K/Akt/mTOR pathway markers in breast cancer.
Type of Anesthesia May Influence Breast Cancer Recurrence Post-Surgery
In vitro studies demonstrated a reduced incidence of apoptosis in patients administered inhaled anesthetics compared with those administered propofol during surgery.
In the Literature: PD-L1 Overexpression Associated With Activating EGFR Mutation in NSCLC
High expression of PD-L1 was associated with the presence of EGFR mutations in surgically resected NSCLC and was an independent negative prognostic factor for this disease.
Hospitals, Regulators Spar Over In-Patient Care Policy
Fewer patients linger for days in hospitals without being admitted because of a new federal rule, but hospital and consumer groups are suing the government because they say the policy compromises Medicare patients' care, and patients are often stuck with costly, unexpected bills.
Better Rules Needed to Boost Use of Big Data
It's easy to get swept up in the swelling enthusiasm for using the explosion in electronic health and claims records to improve every aspect of healthcare. But the era of “big data” isn't going to happen without better federal rules for stimulating its uses and preventing abuses.
Encouraging Response to Roche's New MEK-Inhibitor in Melanoma Patients
Cobimetinib (MEK inhibitor), used in combination with Zelboraf (BRAF inhibitor), improved survival without disease progression.
Physician Pay Increasingly Linked to Value-based Metrics
Primary care doctors surveyed by the Medical Group Management Association say nearly 6% of their compensation was pegged to quality metrics in 2013, up from 3% in 2012.
House GOP Moves Ahead on Suing Obama
House Republicans took the initial step on Thursday to sue President Barack Obama over the administration's decision to delay the employer mandate of the healthcare law.
BMS to Seek Approval for Nivolumab in the US to Treat Advanced Melanoma
Following approval in Japan, Nivolumab will be evaluated by the FDA for melanoma therapy in the US.
Koh Departing Obama Administration
Dr. Howard Koh is stepping down as assistant secretary for health at HHS after five years in the post. Koh's primary focus was disease prevention, including oversight of the Office of the Surgeon General.
Cancer Patients Appreciate the Convenience of MyChart, Says Study
There has been a sharp increase in the number of cancer patients at one hospital using MyChart, the online, interactive service that allows patients to view laboratory and radiology results, communicate with their healthcare providers, and more.
New Form of US Healthcare Saves Money, Improves Quality, One Insurer Finds
In one of the largest tests of a novel way to deliver and pay for healthcare, insurer CareFirst BlueCross BlueShield announced on Thursday that 1.1 million people receiving care through its "patient-centered medical homes" last year were hospitalized less often and stayed for fewer days compared to patients in traditional fee-for-service care.
In The Literature: Molecular Landscape of Lung Adenocarcinoma Published
Collaborative research conducted by scientists within the Cancer Genome Atlas Research Network have identified significant mutations that can influence tumor subtype classification.
Will Health Reform Bring New Role, Respect To Primary Care Physicians?
While much attention has focused on expanded coverage and online insurance bazaars, policymakers’ bigger challenge is improving Americans’ health while putting a brake on the cost of their care. The keys to that puzzle, CareFirst and many others are deciding, are the internists and general practitioners who have largely been left behind by health care’s financial boom.
UnitedHealthcare's Oncology Payment Model Shows Promise
UnitedHealthcare published these findings in the latest issue of Journal of Oncology Practice.
Pseudogenes: Novel Biomarkers For Identifying Tumor Subtypes?
The study by researchers at MD Anderson Cancer Center raises the possibility of using the information provided by these dysfunctional genes.
High Hurdles: Leaders of Patient Care Organizations Participating in Medicare’s ACO Programs are Pushing Ahead Into the New Healthcare
The leaders of ACOs are working their way through a welter of immediate and longer-term issues.
Aetna Sees Promise in New Heart Disease Diagnostic
With spending on diagnostics alone for cardiovascular disease likely to be a major challenge for insurers amid the baby boom wave, Aetna is turning to an emerging option as part of a strategy to avoid invasive tests and treatments.
Eradicating Silos and Improving Communication in Cancer Care
Several cancer centers have programs in place to improve communication between PCPs and oncologists.
HHS Announces the Availability of $100M in ACA Funding to Expand Access to Primary Care Through New Community Health Centers
HHS Secretary Sylvia Mathews Burwell announced today the availability of $100 million from the Affordable Care Act to support an estimated 150 new health center sites across the country in 2015.
Biomarker-Directed, MS-Based Precision Surgery for Brain Cancer
A lipid metabolite, associated with more than 70 percent of brain cancers, can help distinguish and excise cancerous tissue.